Quantcast

Latest Carcinoid Stories

2014-02-21 23:03:28

BerriHealth continues to support research for the neuroendocrine tumor and carcinoid cancer community. Portland, Oregon (PRWEB) February 21, 2014 BerriHealth, a leader in providing high-quality black raspberry powder for clinical trials and directly to consumers online, has donated a portion of their 2013 sales to New Orleans Louisiana Neuroendocrine Tumor Specialists (NOLANETS), led by Dr. Eugene Woltering. The program is a collaborative effort between the Louisiana State University...

2014-02-14 23:04:29

From Patient to Survivor: Author’s Medical Background and Own Cancer Experience Provides Insight and Inspiration for Rare Type of Cancer San Francisco (PRWEB) February 14, 2014 Over 90% of all carcinoid and neuroendocrine tumors are incorrectly diagnosed and treated for the wrong disease. Maria Gonzalez, MSN, FNP/PA-C, hopes to help reverse this trend by increasing the awareness of this rare and poorly understood type of cancer. Her new book, “But You Look So Good… Stories by...

2014-01-29 16:29:03

DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/q8l6jf/lexicons) has announced the addition of the "Lexicon's telotristat - A new approach to carcinoid syndrome" [http://www.researchandmarkets.com/research/q8l6jf/lexicons ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Lexicon is developing telotristat as therapy for carcinoid syndrome, an orphan' disease that occurs...

2013-06-25 23:01:51

BerriProducts LLC, an Oregon-based supplier of premium quality black raspberry products shares news from the recently-attended Berry Health Benefits Symposium on angiogenesis inhibition with an in vitro test on human carcinoid cancer cells Charlotte, North Carolina (PRWEB) June 25, 2013 Dr. Eugene Woltering, Section Chief of Surgical Endocrinology at the Louisiana State University Health Sciences Center in New Orleans presented some results of his work on neuroendocrine tumors (NETS)....

2012-10-20 04:00:03

The Philly NETs (neuroendocrine tumor cancers) and its patient community will celebrate the 3rd annual worldwide NET Cancer Awareness Day on November 10th at the Philadelphia Zoo with its inaugural 5K “Deb´s Run for The Stripes”. PhillyNETs is the sponsoring group in partnership with the Patients´ Project, a local nonprofit addressing the issue of health literacy. The Run will benefit University of Pennsylvania´s Abramson Cancer Center´s Neuroendocrine Tumor...

2011-11-30 10:45:17

Combination treatment with octreotide shows improved results in tumors associated with carcinoid syndrome Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center. Results of the international, randomized, placebo-controlled...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related